Biotech

All Articles

ArsenalBio increases $325M, pivots out of previous lead possession

.Toolbox Biosciences is actually going on up. The tissue therapy firm has actually added $325 millio...

Lilly- backed fat loss biotech files IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to...

Aelis' cannabis make use of medication fails stage 2b, driving Indivior to re-think $100M option

.Aelis Farma's chances of protecting a fast, beneficial choice on a $one hundred million alternative...

ProKidney halts phase 3 trial not needed to have for cell therapy confirmation

.ProKidney has actually ceased among a set of phase 3 trials for its tissue therapy for kidney illne...

Vaxcyte rises on 'stunning' 31-valent PCV succeed against Pfizer

.Vaxcyte revealed what experts referred to as "magnificent" period 1/2 information for its own 31-va...

Recursion's mind illness trial reveals scant evidence of efficacy

.Recursion has actually stumbled by means of a very early exam of its own tech-enabled technique to ...

Acepodia, Pfizer click together for chemistry-based tissue treatment

.Contact it a case of really good chemistry: Acepodia, a biotech based on Nobel Champion science, is...

Praxis epilepsy drug decreases confiscations in stage 2 litigation

.Praxis Preciseness Medicines has scored yet another midphase win in epilepsy this year, with its ow...

Three directors surrender as Dyne articles blended information for DMD candidate

.After leaving a clinical hold a number of years back, Dyne Therapy has uncovered brand-new phase 1/...

Arrowhead fires off period 3 records in rare metabolic disease before market encounter Ionis

.Arrowhead Pharmaceuticals has revealed its own hand in front of a prospective showdown along with I...